![Robin Swartz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robin Swartz
Verksamhetschef på
VOYAGER THERAPEUTICS, INC.
Förmögenhet: 988 384 $ per 2026-08-31
Profil
Robin Swartz is Chief Operating Officer & Business Officer at Voyager Therapeutics, Inc. since 2024.
Former roles include Director at Sanofi-Aventis, Inc., Vice President-Patient & Product Services at Genzyme Corp., and Vice President-Product Services at Genzyme Therapeutics Ltd. from 2018 to 2020.
Education includes undergraduate studies at Kenyon College.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 286 488 ( 0,46 % ) | 988 384 $ | 2026-08-31 |
Aktiva positioner av Robin Swartz
| Företag | Position | Start |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Verksamhetschef | 2022-02-01 |
Tidigare kända positioner av Robin Swartz
| Företag | Position | Slut |
|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Företagsledare/Principal | 2020-06-01 |
Sanofi-Aventis, Inc.
 Sanofi-Aventis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Direktör/Styrelseledamot | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | - |
Robin Swartzs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
35
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Kenyon College
 Kenyon College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Sanofi-Aventis, Inc.
Sanofi-Aventis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
